2020年3月至2021年6月法国所有重症COVID-19成人住院患者临床特征与结局趋势:一项全国数据库研究
该研究为法国全国回顾性队列研究,纳入2020年3月1日至2021年6月30日所有入住法国ICU的成人COVID-19患者,划分为三个疫情高峰时段。共105,979例危重患者,三个时段的院内死亡率分别为24%、27%、24%,有创机械通气作为最高呼吸支持的比例分别为42%、32%、31%(p < 0.001),血管升压药使用随时间下降。校正年龄、性别、合并症和入ICU时改良简化急性生理评分II后,时段与较少有创机械通气和较高院内死亡风险相关;接种COVID-19疫苗与较低的有创机械通气可能(aSHR=0.64 [0.53-0.76])和院内死亡可能(aSHR=0.80 [0.68-0.95])相关。
要点
- 三个高峰时段院内死亡率分别为24%、27%、24%,有创机械通气比例分别为42%、32%、31%(p < 0.001)。
- 有创机械通气作为最高呼吸支持的比例随时间下降,血管升压药使用亦下降。
- 接种COVID-19疫苗与较低的有创机械通气风险相关(aSHR=0.64 [0.53-0.76])。
- 接种COVID-19疫苗与较低的院内死亡风险相关(aSHR=0.80 [0.68-0.95])。
适用人群与场景
- 2020年3月1日至2021年6月30日入住法国ICU的所有成人COVID-19患者。
研究设计与关键结果
- 研究类型:全国回顾性队列研究;样本量:105,979例ICU收治的COVID-19危重成人患者;时段:2020年3月1日至2021年6月30日,划分三个疫情高峰时段。
- 主要终点:院内死亡率在高峰1、2、3分别为24%、27%、24%。
- 次要终点:有创机械通气作为最高呼吸支持的比例在高峰1、2、3分别为42%、32%、31%(p < 0.001),血管升压药使用随时间下降。
- 校正年龄、性别、合并症和入ICU时改良简化急性生理评分II后,时段与较少有创机械通气和较高院内死亡风险相关。
- 接种COVID-19疫苗与较低的有创机械通气可能相关(aSHR=0.64 [0.53-0.76])和较低的院内死亡可能相关(aSHR=0.80 [0.68-0.95])。
证据类型、等级与局限
- 证据类型:全国回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究提示随时间推移有创机械通气、血管升压药和肾脏替代治疗使用下降,但院内死亡风险仍高。
- 接种COVID-19疫苗与较低的有创机械通气及院内死亡风险相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Studies regarding coronavirus disease 2019 (COVID-19) were mainly performed in the initial wave, but some small-scale data points to prognostic differences for patients in successive waves. We therefore aimed to study the impact of time on prognosis of ICU-admitted COVID-19 patients.
METHOD: We performed a national retrospective cohort study, including all adult patients hospitalized in French ICUs from March 1, 2020 to June 30, 2021, and identified three surge periods. Primary and secondary outcomes were in-hospital mortality and need for invasive mechanical ventilation, respectively.
RESULTS: 105,979 critically ill ICU-admitted COVID-19 patients were allocated to the relevant three surge periods. In-hospital mortality for surges 1, 2, and 3 was, respectively, 24%, 27%, and 24%. Invasive mechanical ventilation was the highest level of respiratory support for 42%, 32%, and 31% (p < 0.001) over the whole period, with a decline in the use of vasopressors over time. Adjusted for age, sex, comorbidities, and modified Simplified Acute Physiology Score II at ICU admission, time period was associated with less invasive mechanical ventilation and a high risk of in-hospital death. Vaccination against COVID-19 was associated with a lower likelihood of invasive mechanical ventilation (adjusted sub-hazard ratio [aSHR] = 0.64 [0.53-0.76]) and intra-hospital death (aSHR = 0.80, [0.68-0.95]).
CONCLUSION: In this large database of ICU patients admitted for COVID-19, we observed a decline in invasive mechanical ventilation, vasopressors, and RRT use over time but a high risk of in-hospital death. Vaccination was identified as protective against the risk of invasive mechanical ventilation and in-hospital death.
参考来源
- Naouri D, Vuagnat A, Beduneau G, et al. Trends in clinical characteristics and outcomes of all critically ill COVID-19 adult patients hospitalized in France between March 2020 and June 2021: a national database study. Ann Intensive Care. 2023. PMID: 36631602. doi:10.1186/s13613-022-01097-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。